期刊文献+

丙泊酚用于老年心脏病人口腔颌面部手术全麻气管插管的观察

Observation on Effects of Propofol During Anesthetic Induction and Nasotrachcal Intubation for Oral Maxillofacial Surgical Patients with Older Cardiovascular Diseases
下载PDF
导出
摘要 [目的]:观察丙泊酚用于老年心脏病病人行口腔颌面部手术时全麻诱导并经鼻气管插管情况.[方法]:选用65例老年心脏病病人行口腔颌面部手术用丙泊酚诱导并与硫贲妥钠相对比,观察插管前及插管后1、3、5 min不同时段血液动力学指标情况.[结果]:插管前两组平均动脉压(MAP),心率(HR)无显著性差异(P>0.05);插管后1、3、5 min不同时段丙泊酚组血液动力学波动明显低于硫贲妥钠组,二者有显著差异(P<0.01).[结论]:丙泊酚用于老年心脏病人行鼻腔插管优于硫贲妥钠等药物. [ Objective ] To observe on effects of propofol during anesthetic induction and nasotrachcal intubation for oral maxillofacial surgical patients with older cardiovascular diseases. [ Methods ] In 65 patients with older cardiovascular diseases, ASA grade Ⅱto Ⅲ, undergoing oral maxillofacial surgery, the effect of new intravenous anesthetic Propofol was studied during anesthetic induction and nasotracheal intubation, and compared with control group( Sodium Thiopental). [ Results ] To showed hemodynamics such as mean arterial pressure ( MAP), heart rate (HR) hadn' t any significant differences between two groups before nasotracheal intubation ( P 〉 0. 05 ), But the hemodynamies had significant differences between two groups at 1,3 and 5 mins after nasotracheal intubation ( P 〈 0. 01 ), Arrhythmias in Propofol group are less significant than in contrast group. [ Conclusion] That it is better to use Propofal than Thiopental in patients with older cardiovascular diseases for oral maxillofacial surgery in the period of anesthetic induction and nasotracheal intubation.
机构地区 大连市口腔医院
出处 《大连大学学报》 2007年第3期109-111,共3页 Journal of Dalian University
关键词 丙泊酚 老年心脏病 口腔 鼻腔插管术 Propofol cardiovascular diseases stomatological nasotracheal intubation
  • 相关文献

参考文献4

二级参考文献23

  • 1徐辉,张马忠,张跃.年龄对丙泊酚药效学的影响[J].医学理论与实践,2004,17(9):1026-1028. 被引量:3
  • 2Bouillon T, Bruhm J, Radu Radulescu L,et al. Non-steady state analysis of the pharmacokinetic interaction between propofol and remifentanil.Anesthesiology, 2002,97 : 1350-1362.
  • 3Bjorksten AR, Chan C, Crankshaw DP. Determination of remifentanil in human blood by capillary gas chromatography with nitrogen-selective detection. J Chromatogr B Analyt Technol Biomed Life Sci, 2002,775:97-101.
  • 4Minto CF, Schnider TW, Egan TD, et al. Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I . Model development. Anesthesiology, 1997,86 : 10-23.
  • 5Egan TD, Huizinga B, Gupta SK, et al. Remifentanil pharmacokinefies in obese versus lean patients. Anesthesiology, 1998,89:562-573.
  • 6Dover DR, Lemmens HJ. Population pharmacodynamics and pharmacokinetics of remifentanil as a supplement to nitrous oxide anesthesia for elective abdominal surgery. Anesthesiology, 1998,89: 869-877.
  • 7Merten M J, Engbers FH, Burro AG, et al. Predictive performance of computer-controlled infusion of remifentanil during propofol/remifentanil anaesthesia. Br J Anaesth,2003,90:132-141.
  • 8Hoymork SC, Reder J, Grmsmo B, et al. Bispectral index, predicted and measured drug level of target controlled infusions of remifentanil and propofol during laparoscopic cholecystectomy and emergenced. Acta Anaesth Stand, 2000,44:1138-1144.
  • 9Crankshaw DP, Chan C, Leslie K, et al. Remifentanil concentration during target-controlled infusion of propofol. Anaesth Intensive Care,2002,30:578-583.
  • 10Lang E, Kaplia A, Shlugman D, et al. Reduction of isoflurane minimal alveolar concentration by remifentanil. Anesthesiology, 1996, 85: 721-728.

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部